Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. USO
2. COST
3. SPY
4. IBM
5. MSFT
6. BX
7. CG
8. OWL
9. RIO
10. BHP

Go back to Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray
APTARGROUP, Inc. (NYSE: ATR) Delayed: 124.21 --0 (-0%)
Previous Close $124.21    52 Week High $81.50 
Open $124.21    52 Week Low $66.33 
Day High $124.21    P/E 49.29 
Day Low $124.21    EPS $2.52 
Volume 201